Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study

2013262 citationsJournal Articlegreen Open Access

Authors

Nicolas Gaspard · Yale University

Brandon Foreman · Columbia University Irving Medical Center

Lilith M. Judd · Emory University

J. Nicholas Brenton · University of Virginia

Barnett R. Nathan · University of Virginia

Bláthnaid McCoy · Hospital for Sick Children

Ali Al‐Otaibi ·

Abstract

Ketamine appears to be a relatively effective and safe drug for the treatment of RSE. This retrospective series provides preliminary data on effective dose and appropriate time of intervention to aid in the design of a prospective trial to further define the role of ketamine in the treatment of RSE.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Epilepsia

Volume 54, Issue 8, pp. 1498-1503

DOI: 10.1111/epi.12247

Field-Weighted Citation Impact: 12.26